S&P 500
(0.08%) 5 252.57 points
Dow J
(0.04%) 39 776 points
Nasdaq
(-0.11%) 16 381 points
Oil
(2.00%) $82.98
Gas
(1.28%) $1.740
Gold
(1.30%) $2 241.50
Silver
(0.97%) $24.99
Platinum
(1.37%) $922.15
USD/EUR
(0.28%) $0.926
USD/NOK
(0.71%) $10.84
USD/GBP
(0.09%) $0.792
USD/RUB
(0.14%) $92.57

Realtime updates for Pfizer Inc [PFE.DE]

Exchange: XETRA Sector: Pharmaceuticals Industry: Drug Manufacturers—General
Last Updated28 Mar 2024 @ 12:35

0.39% 25.85

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 12:35):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands...

Stats
Today's Volume 97 758.00
Average Volume 117 920
Market Cap 145.97B
EPS €0 ( 2024-01-30 )
Next earnings date ( €0 ) 2024-04-29
Last Dividend €0.410 ( 2023-07-27 )
Next Dividend €0 ( N/A )
P/E 76.03
ATR14 €0.0360 (0.14%)

Volume Correlation

Long: -0.09 (neutral)
Short: 0.00 (neutral)
Signal:(54.128) Neutral

Pfizer Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pfizer Inc Correlation - Currency/Commodity

The country flag -0.16
( neutral )
The country flag -0.08
( neutral )
The country flag 0.00
( neutral )
The country flag 0.16
( neutral )
The country flag -0.59
( weak negative )
The country flag 0.15
( neutral )

Pfizer Inc Financials

Annual 2023
Revenue: €58.50B
Gross Profit: €33.54B (57.34 %)
EPS: €0.380
Q4 2023
Revenue: €14.25B
Gross Profit: €1.14B (7.97 %)
EPS: €-0.600
Q3 2023
Revenue: €13.23B
Gross Profit: €3.96B (29.95 %)
EPS: €-0.420
Q2 2023
Revenue: €12.73B
Gross Profit: €9.50B (74.58 %)
EPS: €0.410

Financial Reports:

No articles found.

Pfizer Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€0.400
(N/A)
€0.400
(N/A)
€0.410
(N/A)
€0.410
(N/A)
€0.410
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

Pfizer Inc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 6.07 - average (69.29%) | Divividend Growth Potential Score: 4.01 - Stable (19.70%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €0.325 2008-01-11
Last Dividend €0.410 2023-07-27
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 68 --
Total Paid Out €20.64 --
Avg. Dividend % Per Year 0.00% --
Score 3.69 --
Div. Sustainability Score 6.07
Div.Growth Potential Score 4.01
Div. Directional Score 5.04 --
Next Divdend (Est)
(2024-04-05)
€0.419 Estimate 29.88 %
Dividend Stability
0.80 Good
Dividend Score
3.69
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SOBA.DE Ex Dividend Knight 2023-07-07 Quarterly 0 0.00%
DTE.DE Ex Dividend Junior 2023-04-06 Annually 0 0.00%
LUS1.F Ex Dividend Junior 2023-06-23 Annually 0 0.00%
AEIN.DE Ex Dividend Knight 2023-06-14 Annually 0 0.00%
UN9.DE Ex Dividend Junior 2023-06-15 Annually 0 0.00%
FMC1.DE Ex Dividend Knight 2023-07-24 Semi-Annually 0 0.00%
NTH.DE Ex Dividend Knight 2023-08-25 Quarterly 0 0.00%
BEI.DE Ex Dividend Knight 2023-04-14 Annually 0 0.00%
XTP.F No Dividend Player 2023-05-12 Sporadic 0 0.00%
HBH.DE Ex Dividend Junior 2023-07-10 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.03671.5009.2710.00[0 - 0.5]
returnOnAssetsTTM0.009471.2009.6810.00[0 - 0.3]
returnOnEquityTTM0.02221.500-0.864-1.296[0.1 - 1]
payoutRatioTTM4.31-1.00010.00-10.00[0 - 1]
currentRatioTTM0.9070.800-0.467-0.373[1 - 3]
quickRatioTTM0.5830.800-1.279-1.023[0.8 - 2.5]
cashRatioTTM0.05971.500-0.779-1.169[0.2 - 2]
debtRatioTTM0.313-1.5004.79-7.18[0 - 0.6]
interestCoverageTTM0.5511.000-0.907-0.907[3 - 30]
operatingCashFlowPerShareTTM1.5552.009.4810.00[0 - 30]
freeCashFlowPerShareTTM0.8562.009.5710.00[0 - 20]
debtEquityRatioTTM0.796-1.5006.82-10.00[0 - 2.5]
grossProfitMarginTTM0.4791.0005.365.36[0.2 - 0.8]
operatingProfitMarginTTM0.02081.000-1.584-1.584[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1231.000-0.429-0.429[0.2 - 2]
assetTurnoverTTM0.2580.800-1.612-1.289[0.5 - 2]
Total Score6.07

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM72.711.0002.760[1 - 100]
returnOnEquityTTM0.02222.50-0.555-1.296[0.1 - 1.5]
freeCashFlowPerShareTTM0.8562.009.7110.00[0 - 30]
dividendYielPercentageTTM5.921.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.5552.009.4810.00[0 - 30]
payoutRatioTTM4.311.50010.00-10.00[0 - 1]
pegRatioTTM-2.591.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1491.0008.780[0.1 - 0.5]
Total Score4.01

Pfizer Inc

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators